Related Experiment Video
Updated: Sep 17, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Prevalence of and differences in participation restrictions among US cancer survivors
Todd Burus1, Nicholas Lamar Wright2, Jennifer D Burus3
1Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA.
Abstract:
Being diagnosed with cancer and undergoing cancer treatment can have detrimental effects on the physical and mental functioning of individuals. Understanding the prevalence and specific differences in functioning difficulties experienced by cancer survivors can enhance future research. In this cross-sectional study of self-reported functioning, we used a United States (US) nationally representative sample of adults aged ≥20 years (n = 7764) to assess for differences in the prevalence of participation restrictions based on the global standard Washington Group on Disability Statistics Short Set on Functioning. We measured differences using adjusted prevalence ratios (aPR) with 95% confidence intervals (CI), adjusted for sex, age, race and ethnicity, and educational attainment. Significant aPR differences were determined based on 95% CIs not including 1. Our final analytic sample included 908 cancer survivors (weighted prevalence, 9.1%; 95% CI, 8.4%-9.8%). We estimated that participation restrictions were 43.3% more common among cancer survivors than individuals with no cancer history (aPR, 1.433; 95% CI, 1.202-1.709). Among specific domains of functioning, cancer survivors experienced a significantly greater prevalence of difficulties with seeing, hearing, mobility, communicating, cognition, self-care, and upper-body functioning. Given the increasing number of cancer survivors in the US, it is crucial to develop interventions to reduce participation restrictions among this population and provide equal opportunities to fully engage in life without additional barriers.
Related Concept Videos
Cancer Survival Analysis
Comparing the Survival Analysis of Two or More Groups
Treatment Resistant Cancers
Longitudinal Research
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

